GO:0071840 | cellular component organization or biogenesis | 5.76% (11/191) | 3.37 | 0.0 | 2e-06 |
GO:0016043 | cellular component organization | 5.76% (11/191) | 3.46 | 0.0 | 2e-06 |
GO:0003676 | nucleic acid binding | 12.04% (23/191) | 1.89 | 0.0 | 7e-06 |
GO:0006260 | DNA replication | 2.62% (5/191) | 5.55 | 0.0 | 9e-06 |
GO:0005488 | binding | 26.7% (51/191) | 1.0 | 1e-06 | 4.8e-05 |
GO:1901363 | heterocyclic compound binding | 18.32% (35/191) | 1.25 | 1e-06 | 7.7e-05 |
GO:0097159 | organic cyclic compound binding | 18.32% (35/191) | 1.25 | 1e-06 | 7.7e-05 |
GO:0090304 | nucleic acid metabolic process | 5.76% (11/191) | 2.66 | 2e-06 | 7.8e-05 |
GO:0003677 | DNA binding | 6.81% (13/191) | 2.33 | 2e-06 | 0.000102 |
GO:0006259 | DNA metabolic process | 3.14% (6/191) | 3.77 | 6e-06 | 0.000217 |
GO:0006139 | nucleobase-containing compound metabolic process | 6.28% (12/191) | 2.31 | 7e-06 | 0.000243 |
GO:0046483 | heterocycle metabolic process | 6.28% (12/191) | 2.18 | 1.7e-05 | 0.000502 |
GO:0003674 | molecular_function | 36.13% (69/191) | 0.67 | 1.7e-05 | 0.00052 |
GO:0006725 | cellular aromatic compound metabolic process | 6.28% (12/191) | 2.15 | 2.1e-05 | 0.000559 |
GO:0140513 | nuclear protein-containing complex | 2.62% (5/191) | 3.88 | 2.5e-05 | 0.000582 |
GO:1901360 | organic cyclic compound metabolic process | 6.28% (12/191) | 2.13 | 2.4e-05 | 0.000609 |
GO:0009987 | cellular process | 17.28% (33/191) | 1.04 | 5.8e-05 | 0.001276 |
GO:0008150 | biological_process | 21.99% (42/191) | 0.86 | 8.1e-05 | 0.001703 |
GO:0071103 | DNA conformation change | 1.57% (3/191) | 5.01 | 0.000111 | 0.002211 |
GO:0140535 | intracellular protein-containing complex | 2.09% (4/191) | 3.86 | 0.000177 | 0.003338 |
GO:0017056 | structural constituent of nuclear pore | 1.05% (2/191) | 6.43 | 0.000228 | 0.004099 |
GO:0065003 | protein-containing complex assembly | 2.09% (4/191) | 3.56 | 0.00039 | 0.006391 |
GO:0032991 | protein-containing complex | 4.71% (9/191) | 2.04 | 0.000387 | 0.006627 |
GO:0043933 | protein-containing complex organization | 2.09% (4/191) | 3.44 | 0.000537 | 0.008433 |
GO:0051276 | chromosome organization | 1.57% (3/191) | 4.23 | 0.00056 | 0.008447 |
GO:0006325 | chromatin organization | 1.57% (3/191) | 4.17 | 0.000632 | 0.009159 |
GO:0005643 | nuclear pore | 1.05% (2/191) | 5.65 | 0.00071 | 0.00991 |
GO:1990234 | transferase complex | 1.57% (3/191) | 3.96 | 0.000975 | 0.01186 |
GO:0032508 | DNA duplex unwinding | 1.05% (2/191) | 5.43 | 0.000974 | 0.012244 |
GO:0032392 | DNA geometric change | 1.05% (2/191) | 5.43 | 0.000974 | 0.012244 |
GO:0022607 | cellular component assembly | 2.09% (4/191) | 3.22 | 0.000942 | 0.012685 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.62% (5/191) | 2.63 | 0.001378 | 0.016239 |
GO:0008017 | microtubule binding | 1.57% (3/191) | 3.73 | 0.001546 | 0.01766 |
GO:0032774 | RNA biosynthetic process | 2.09% (4/191) | 3.0 | 0.001643 | 0.018213 |
GO:0019001 | guanyl nucleotide binding | 3.66% (7/191) | 2.04 | 0.001711 | 0.018425 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.81% (13/191) | 1.37 | 0.001801 | 0.018863 |
GO:0015631 | tubulin binding | 1.57% (3/191) | 3.57 | 0.002127 | 0.021668 |
GO:0065007 | biological regulation | 4.71% (9/191) | 1.65 | 0.002555 | 0.02535 |
GO:0017076 | purine nucleotide binding | 8.38% (16/191) | 1.15 | 0.002629 | 0.025414 |
GO:0006996 | organelle organization | 1.57% (3/191) | 3.34 | 0.003329 | 0.02728 |
GO:1903504 | regulation of mitotic spindle checkpoint | 0.52% (1/191) | 8.23 | 0.003324 | 0.027849 |
GO:0031491 | nucleosome binding | 0.52% (1/191) | 8.23 | 0.003324 | 0.027849 |
GO:0008083 | growth factor activity | 0.52% (1/191) | 8.23 | 0.003324 | 0.027849 |
GO:1901976 | regulation of cell cycle checkpoint | 0.52% (1/191) | 8.23 | 0.003324 | 0.027849 |
GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint | 0.52% (1/191) | 8.23 | 0.003324 | 0.027849 |
GO:0090231 | regulation of spindle checkpoint | 0.52% (1/191) | 8.23 | 0.003324 | 0.027849 |
GO:0018130 | heterocycle biosynthetic process | 2.62% (5/191) | 2.32 | 0.003474 | 0.027868 |
GO:0019438 | aromatic compound biosynthetic process | 2.62% (5/191) | 2.3 | 0.003674 | 0.028266 |
GO:0000166 | nucleotide binding | 8.38% (16/191) | 1.09 | 0.00389 | 0.028758 |
GO:1901265 | nucleoside phosphate binding | 8.38% (16/191) | 1.09 | 0.00389 | 0.028758 |
GO:0051983 | regulation of chromosome segregation | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0033045 | regulation of sister chromatid segregation | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0042176 | regulation of protein catabolic process | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0000228 | nuclear chromosome | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0009894 | regulation of catabolic process | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0000502 | proteasome complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0003896 | DNA primase activity | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:1905818 | regulation of chromosome separation | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0007088 | regulation of mitotic nuclear division | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0010965 | regulation of mitotic sister chromatid separation | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0051783 | regulation of nuclear division | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0000151 | ubiquitin ligase complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0000152 | nuclear ubiquitin ligase complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0005680 | anaphase-promoting complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0007346 | regulation of mitotic cell cycle | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0005762 | mitochondrial large ribosomal subunit | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0042575 | DNA polymerase complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0006433 | prolyl-tRNA aminoacylation | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0004827 | proline-tRNA ligase activity | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0043625 | delta DNA polymerase complex | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0000315 | organellar large ribosomal subunit | 0.52% (1/191) | 7.23 | 0.006637 | 0.028761 |
GO:0035639 | purine ribonucleoside triphosphate binding | 7.85% (15/191) | 1.14 | 0.003667 | 0.028799 |
GO:0032555 | purine ribonucleotide binding | 7.85% (15/191) | 1.12 | 0.004079 | 0.029574 |
GO:0003924 | GTPase activity | 2.62% (5/191) | 2.26 | 0.004209 | 0.029937 |
GO:0005525 | GTP binding | 3.14% (6/191) | 1.84 | 0.00707 | 0.02995 |
GO:0032561 | guanyl ribonucleotide binding | 3.14% (6/191) | 1.84 | 0.00707 | 0.02995 |
GO:0032553 | ribonucleotide binding | 7.85% (15/191) | 1.11 | 0.004375 | 0.030541 |
GO:0050789 | regulation of biological process | 4.19% (8/191) | 1.51 | 0.007663 | 0.032099 |
GO:0097367 | carbohydrate derivative binding | 7.85% (15/191) | 1.09 | 0.004934 | 0.033819 |
GO:1901362 | organic cyclic compound biosynthetic process | 2.62% (5/191) | 2.19 | 0.005112 | 0.034415 |
GO:0036094 | small molecule binding | 8.38% (16/191) | 1.03 | 0.005591 | 0.03513 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.05% (2/191) | 4.19 | 0.005423 | 0.035252 |
GO:0044877 | protein-containing complex binding | 1.05% (2/191) | 4.19 | 0.005423 | 0.035252 |
GO:1902494 | catalytic complex | 2.09% (4/191) | 2.51 | 0.005566 | 0.035565 |
GO:0008154 | actin polymerization or depolymerization | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0033044 | regulation of chromosome organization | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0006269 | DNA replication, synthesis of RNA primer | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0032784 | regulation of DNA-templated transcription elongation | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0030041 | actin filament polymerization | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0051258 | protein polymerization | 0.52% (1/191) | 6.65 | 0.009939 | 0.03603 |
GO:0016070 | RNA metabolic process | 2.62% (5/191) | 1.95 | 0.01011 | 0.036302 |
GO:0043168 | anion binding | 7.85% (15/191) | 1.0 | 0.008799 | 0.036453 |
GO:0097747 | RNA polymerase activity | 1.05% (2/191) | 3.68 | 0.010771 | 0.037949 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.05% (2/191) | 3.68 | 0.010771 | 0.037949 |
GO:0006338 | chromatin remodeling | 1.05% (2/191) | 3.74 | 0.009907 | 0.039733 |
GO:0043231 | intracellular membrane-bounded organelle | 2.09% (4/191) | 2.28 | 0.009708 | 0.039783 |
GO:0043227 | membrane-bounded organelle | 2.09% (4/191) | 2.27 | 0.009842 | 0.039896 |
GO:0005575 | cellular_component | 9.95% (19/191) | 0.91 | 0.006549 | 0.040474 |
GO:0003723 | RNA binding | 3.66% (7/191) | 1.52 | 0.011698 | 0.040834 |
GO:0008092 | cytoskeletal protein binding | 1.57% (3/191) | 2.66 | 0.012277 | 0.042464 |
GO:0098772 | molecular function regulator activity | 1.57% (3/191) | 2.65 | 0.012509 | 0.04287 |
GO:0048018 | receptor ligand activity | 0.52% (1/191) | 6.23 | 0.013231 | 0.044141 |
GO:0030545 | signaling receptor regulator activity | 0.52% (1/191) | 6.23 | 0.013231 | 0.044141 |
GO:0030546 | signaling receptor activator activity | 0.52% (1/191) | 6.23 | 0.013231 | 0.044141 |
GO:0003777 | microtubule motor activity | 1.05% (2/191) | 3.5 | 0.013553 | 0.044429 |
GO:0007018 | microtubule-based movement | 1.05% (2/191) | 3.5 | 0.013553 | 0.044429 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2.09% (4/191) | 2.13 | 0.013739 | 0.044651 |
GO:0005515 | protein binding | 7.33% (14/191) | 0.95 | 0.014614 | 0.04669 |
GO:0003774 | cytoskeletal motor activity | 1.05% (2/191) | 3.35 | 0.016611 | 0.046733 |
GO:0017128 | phospholipid scramblase activity | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0140303 | intramembrane lipid transporter activity | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0045892 | negative regulation of DNA-templated transcription | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0051253 | negative regulation of RNA metabolic process | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0017121 | plasma membrane phospholipid scrambling | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:1901987 | regulation of cell cycle phase transition | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0007009 | plasma membrane organization | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0045332 | phospholipid translocation | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0034204 | lipid translocation | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:1902679 | negative regulation of RNA biosynthetic process | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0097035 | regulation of membrane lipid distribution | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:1905369 | endopeptidase complex | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:0004749 | ribose phosphate diphosphokinase activity | 0.52% (1/191) | 5.91 | 0.016511 | 0.046802 |
GO:1990904 | ribonucleoprotein complex | 1.05% (2/191) | 3.45 | 0.014542 | 0.046857 |
GO:0140677 | molecular function activator activity | 1.05% (2/191) | 3.43 | 0.015048 | 0.047673 |
GO:0005634 | nucleus | 1.57% (3/191) | 2.46 | 0.017657 | 0.04931 |